NGM Past Earnings image   This NGM past earnings page last updated 3/29/2023
NGM Past Earnings
PeriodPast Earnings DateGAAP
Q4 20222/28/2023-0.450
Q3 202211/3/2022-0.590
Q2 20228/4/2022-0.590
Q1 20225/5/2022-0.420
Q4 20213/1/2022-0.350
Q3 202111/4/2021-0.370
Q2 20218/5/2021-0.480
Q1 20215/6/2021-0.360
Q4 20203/4/2021-0.400
Q3 202011/12/2020-0.430
Q2 20208/12/2020-0.380
Q1 20205/13/2020-0.280
Q4 20193/17/2020-0.240
Q3 201911/12/2019-0.170
Q2 20198/12/2019-0.130
Q1 20195/16/2019-1.210
NGM Past Revenue
PeriodPast Earnings DateGAAP
Q4 20222/28/20230.02B
Q3 202211/3/20220.01B
Q2 20228/4/20220.01B
Q1 20225/5/20220.02B
Q4 20213/1/20220.02B
Q3 202111/4/20210.02B
Q2 20218/5/20210.02B
Q1 20215/6/20210.02B
Q4 20203/4/20210.02B
Q3 202011/12/20200.02B
Q2 20208/12/20200.02B
Q1 20205/13/20200.02B
Q4 20193/17/20200.03B
Q3 201911/12/20190.02B
Q2 20198/12/20190.03B
Q1 20195/16/20190.03B
Quotes delayed 20 minutes

Email EnvelopeFree NGM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
NGM Biopharmaceuticals (NGM) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

NKTR Past Earnings
NKTX Past Earnings
NLTX Past Earnings
NMTC Past Earnings
NMTR Past Earnings
NOTV Past Earnings
NOVN Past Earnings
NPCE Past Earnings
NRBO Past Earnings
NRC Past Earnings

NGM Past Earnings Q&A

What was the best and worst NGM past earnings results?
For NGM Biopharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest NGM past earnings result in our data set was -0.130/share posted in Q2 2019, while the lowest was in Q1 2019 when NGM posted -1.210/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2019 when NGM reported 0.03B in revenue, while the quarter with the lowest revenue in our data set was Q3 2022 at 0.01B of revenue.

  Suggested answer: There are 16 NGM past earnings results in our data set.

On this page we presented the NGM past earnings date information for NGM Biopharmaceuticals. Reviewing that NGM Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2019, when NGM posted gaap of -0.130/share. Meanwhile the lowest NGM past earnings result was in Q1 2019, when NGM posted gaap of -1.210/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2019 when NGM reported 0.03B in revenue, while the smallest revenue quarter was Q3 2022 when NGM reported 0.01B in revenue.

Any self directed investor doing their due diligence on NGM or any other given stock can benefit from researching all of the NGM Biopharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate NGM Biopharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NGM. Thanks for visiting, and the next time you need to research NGM past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: SIM Options Chain, NCR YTD Return, WIRE Dividend History.


NGM Past Earnings | | Copyright © 2020 - 2023, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.